CD8A and neoplasm: IFN-γ receptor β chain (IFN-γR2) in CD8+ T cells also restricts anti-tumour responses and again selective deletion of IFN-γR2 reinvigorated stem-like T cells, strengthening anti-tumour immunity [72].